| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.2M | +519.9% |
| Cost of Revenue | $355K | +74.0% |
| R&D Expense | $20.8M | +6.2% |
| SG&A Expense | $11.9M | +0.8% |
| Operating Income | -$24.8M | +17.9% |
| Net Income | -$32.5M | +1.4% |
| EPS (Basic) | -$0.53 | +3.6% |
| EPS (Diluted) | -$0.53 | +3.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.9M | -40.1% |
| Accounts Receivable | $170K | — |
| Current Assets | $30.1M | -39.0% |
| Total Assets | $34.0M | -33.7% |
| Current Liabilities | $6.8M | +17.8% |
| Total Liabilities | $49.9M | +22.7% |
| Stockholders' Equity | -$15.9M | -250.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.1M | -35.7% |
| Capital Expenditures | $1.8M | +622.4% |
| Investing Cash Flow | -$1.8M | -622.4% |
| Financing Cash Flow | $414K | -98.7% |
| Free Cash Flow | -$19.9M | -46.3% |